Published in Genetics and Environmental Business Week, January 18th, 2007
This service allows pathologist customers to participate in the revenue stream derived from fluorescence in-situ hybridization (FISH) testing by letting them professionally analyze and interpret FISH test results on specimens where the technical component of such testing was performed at NeoGenomics Laboratories.
Robert Gasparini, the company's President and Chief Scientific Officer, said, "Our Tech-only FISH product is the first of its kind in the nation and we expect that it will significantly change the way FISH testing services...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.